摘要
目的分析和总结采用经尿道柱状水囊前列腺扩开术治疗中年及高危前列腺增生患者的近期临床疗效和手术要点。方法回顾性分析2016年3-12月,该科收治的30例良性前列腺增生患者,其中9例为小于60岁中年患者,21例高危患者均大于80岁且有各种不同基础疾病,采用新手术方式经尿道柱状水囊前列腺扩开术治疗,按照手术标准流程进行。结果 30例患者均一次手术成功,均于前列腺12点方向扩开至脂肪层,手术时间短,出血量少,并发症发生率6.7%(2/30),术后拔除尿管均排尿通畅。术后随访1-6个月,国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿(RUV)等各项指标与术前比较差异有统计学意义(P<0.05)。结论经尿道柱状水囊前列腺扩开术治疗前列腺增生近期疗效确切,是治疗中年及高危患者良性前列腺增生的补充手术方式。
Objective To analyze and summarize the short-term clinical efficacy and surgical points of transurethral columnar balloon dilation of prostate for middle-aged and high-risk prostatic hyperplasia patients.Methods A total of 30 patients with benign prostatic hyperplasia(BPH)admitted to our department from March 2016 to December 2016 was retrospectively analyzed,including9 middle-aged patients(less than 60 years old)and 21 high-risk patients with various underlying diseases(more than 80 years old).Transurethral columnar balloon dilation of prostate was adopted and performed in accordance with standard operation process.Results All 30 patients were operated successfully by extending their prostate at the direction of 12 o'clock to the fat layer with short operation time and less amount of bleeding.The complication rate was 6.7%(2/30),and the catheter was removed smoothly after the operation.After 1 month and 6 months follow-up,the international prostate symptom score(IPSS),quality of life score(QOL),maximum urinary flow rate(Qmax),residual urine(RUV)and other indicators were analyzed and were statistically significant(P〈0.05).Conclusion Transurethral columnar balloon dilation of prostate is an effective and supplemental method for the treatment of BPH in middle-aged and high-risk patients.
出处
《重庆医学》
CAS
北大核心
2017年第32期4523-4525,共3页
Chongqing medicine
基金
重庆市教委科技基金资助项目(KJ1500207)
关键词
良性前列腺增生
经尿道柱状水囊前列腺扩开术
中年患者
高危患者
benign p.rostatic hyperplasia
transurethral columnar balloon dilation of prostate
middle-aged patients
high-risk patients